{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:55:09Z","timestamp":1794891309460,"version":"4.9.1"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cytogfr.2025.05.007","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T11:14:16Z","timestamp":1748517256000},"page":"120-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"special_numbering":"C","title":["Exploring inflammatory and fibrotic mechanisms driving diabetic nephropathy progression"],"prefix":"10.1016","volume":"84","author":[{"given":"Zeeshan","family":"Ansari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayush","family":"Chaurasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Neha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh Kumar","family":"Bachheti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash Chandra","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2025.05.007_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1497449","article-title":"Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment","volume":"2021","author":"Samsu","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib2","doi-asserted-by":"crossref","DOI":"10.20517\/2574-1209.2024.21","article-title":"Role of inflammation in the progression of diabetic kidney disease","author":"Chatterjee","year":"2024","journal-title":"Vessel"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib4","unstructured":"Randhir. Singh Dahiya, Thakur. Gurjeet Singh, Diabetes and diabetic complications: current status and future perspectives, Nova Science Publishers, 2021."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035397","article-title":"Comprehensive advancements in the prevention and treatment of diabetic nephropathy: a narrative review","volume":"102","author":"Elendu","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib6","article-title":"Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: insights from panvascular diseases","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13148-021-01079-5","article-title":"Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective","volume":"13","author":"Zheng","year":"2021","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib8","doi-asserted-by":"crossref","first-page":"10882","DOI":"10.3390\/ijms252010882","article-title":"Crosstalk of Hyperglycaemia and Cellular Mechanisms in the Pathogenesis of Diabetic Kidney Disease","volume":"25","author":"Efiong","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/ijms22010408","article-title":"Fibrosis in chronic kidney disease: pathogenesis and consequences","volume":"22","author":"Panizo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib10","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3390\/jcm9020458","article-title":"Inflammatory targets in diabetic nephropathy","volume":"9","author":"Donate-Correa","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib11","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.3390\/ijms21113798","article-title":"PathogeniC Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy","volume":"21","author":"Rayego-Mateos","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib12","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/13543784.2018.1538352","article-title":"Targeting inflammation in diabetic nephropathy: a tale of hope","volume":"27","author":"Moreno","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib13","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.3390\/ijms21093172","article-title":"The role of chemokines and chemokine receptors in diabetic nephropathy","volume":"21","author":"Chang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3390\/life13020539","article-title":"The mechanism of hyperglycemia-induced renal cell injury in diabetic nephropathy disease: an update","volume":"13","author":"Wu","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1232790","article-title":"Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms","volume":"14","author":"Xu","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2023.151431","article-title":"Role of inflammation in progression of chronic kidney disease in type 2 diabetes mellitus: clinical implications","volume":"43","author":"Oda","year":"2023","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3904\/kjim.2021.174","article-title":"The role of inflammation in diabetic kidney disease","volume":"36","author":"Jung","year":"2021","journal-title":"Korean J. Intern. Med."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib18","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12882-020-01960-0","article-title":"Renal expression of cytokines and chemokines in diabetic nephropathy","volume":"21","author":"Ara\u00fajo","year":"2020","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00405","article-title":"Interleukin-6 signaling pathway and its role in kidney disease: an update","volume":"8","author":"Su","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/ijms23020647","article-title":"Biological role, mechanism of action and the importance of interleukins in kidney diseases","volume":"23","author":"Mertowska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib21","doi-asserted-by":"crossref","DOI":"10.20517\/2574-1209.2021.11","article-title":"The role of uric acid in renal damage - a history of inflammatory pathways and vascular remodeling","author":"Russo","year":"2021","journal-title":"Vessel"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib22","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","article-title":"The IL-17 family in diseases: from bench to bedside","volume":"8","author":"Huangfu","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib23","doi-asserted-by":"crossref","first-page":"8668","DOI":"10.3390\/ijms23158668","article-title":"Molecular mechanisms of diabetic kidney disease","volume":"23","author":"Rico-Fontalvo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3390\/jpm14070743","article-title":"The role of pro-inflammatory chemokines CCL-1, 2, 4, and 5 in the etiopathogenesis of type 2 diabetes mellitus in subjects from the Asir Region of Saudi Arabia: correlation with different degrees of obesity","volume":"14","author":"Mir","year":"2024","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib25","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S2213-8587(15)00286-7","article-title":"CCR2 inhibition: a panacea for diabetic kidney disease?","volume":"3","author":"Weir","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib26","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/13543784.2016.1196184","article-title":"Targeting inflammation in diabetic kidney disease: early clinical trials","volume":"25","author":"Perez-Gomez","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib27","doi-asserted-by":"crossref","DOI":"10.5603\/EP.a2022.0001","article-title":"Association of chemotactic cytokine receptor 5 (CCR5) gene polymorphism (59029 A\/G, rs1799987) with diabetic kidney disease in patients with type 2 diabetes from Poland","author":"Pokrzywnicka","year":"2022","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.664202","article-title":"Fractalkine (CX3CL1) and its receptor CX3CR1: a promising therapeutic target in chronic kidney disease?","volume":"12","author":"Cormican","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154804","article-title":"The IL-8-CXCR1\/2 axis contributes to diabetic kidney disease","volume":"121","author":"Loretelli","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib30","doi-asserted-by":"crossref","first-page":"8582","DOI":"10.3390\/ijms21228582","article-title":"ThE Role of Chemokine Receptor CXCR3 and its ligands in renal cell carcinoma","volume":"21","author":"Gudowska-Sawczuk","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib31","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1210\/en.2014-1650","article-title":"CXCR4 promotes renal tubular cell survival in male diabetic rats: implications for ligand inactivation in the human kidney","volume":"156","author":"Siddiqi","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41581-024-00911-4","article-title":"Immune\u2013stromal interplay shapes kidney function in health and disease","volume":"21","author":"Raparia","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib33","article-title":"MechanistiC Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib34","article-title":"Roles and crosstalks of macrophages in diabetic nephropathy","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib35","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3390\/biomedicines11071889","article-title":"Relationship between macrophages and tissue microenvironments in diabetic kidneys","volume":"11","author":"Yan","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib36","series-title":"in: Macrophages - Molecular Pathways and Immunometabolic Processes","article-title":"Macrophages: molecular pathways and immunometabolic processes","author":"Ahmad Mir","year":"2024"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/08820139.2024.2302828","article-title":"Advances in metabolic regulation of macrophage polarization state","volume":"53","author":"Liu","year":"2024","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41581-024-00875-5","article-title":"Lymphocytes and innate immune cells in acute kidney injury and repair","volume":"20","author":"Lee","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.intimp.2015.01.003","article-title":"Enalapril treatment increases T cell number and promotes polarization towards M1-like macrophages locally in diabetic nephropathy","volume":"25","author":"Cucak","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.630917","article-title":"Immunomodulatory approaches in diabetes-induced cardiorenal syndromes","volume":"7","author":"Ammar","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-0033-1358666","article-title":"Percentage oF Circulating CD8+\u2009t lymphocytes is associated with albuminuria in type 2 diabetes mellitus","volume":"122","author":"Lei","year":"2013","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib42","article-title":"T cells and their products in diabetic kidney disease","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121661","article-title":"Oxidative stress as a culprit in diabetic kidney disease","volume":"322","author":"Su","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib44","doi-asserted-by":"crossref","first-page":"10395","DOI":"10.3390\/ijms251910395","article-title":"Update on biomarkers of chronic inflammatory processes underlying diabetic neuropathy","volume":"25","author":"Stoian","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib45","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib46","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1042\/BCJ20210139","article-title":"Inhibitory feedback control of NF-\u03baB signalling in health and disease","volume":"478","author":"Prescott","year":"2021","journal-title":"Biochem. J."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib47","article-title":"Immune responses in diabetic nephropathy: pathogenic mechanisms and therapeutic target","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1233259","article-title":"JAK\/STAT signaling in diabetic kidney disease","volume":"11","author":"Liu","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174121","article-title":"JAK\/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes","volume":"902","author":"Chen","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib50","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeae046","article-title":"Myeloid cell-derived interleukin-6 induces vascular dysfunction and vascular and systemic inflammation","volume":"4","author":"Knopp","year":"2024","journal-title":"Eur. Heart J. Open"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113438","article-title":"An examination of the protective effects and molecular mechanisms of curcumin, a polyphenol curcuminoid in diabetic nephropathy","volume":"153","author":"Zhu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13098-025-01655-2","article-title":"Recent advances in understanding the mechanisms by which sodium-glucose co-transporter type 2 inhibitors protect podocytes in diabetic nephropathy","volume":"17","author":"Chen","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3596","article-title":"Role of renal tubular programed cell death in diabetic kidney disease","volume":"39","author":"Zhou","year":"2023","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib54","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ebiom.2019.09.002","article-title":"FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease","volume":"48","author":"Huang","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib55","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2021.05.025","article-title":"AGE\/RAGE in diabetic kidney disease and ageing kidney","volume":"171","author":"Wu","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib56","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/13543784.2016.1196184","article-title":"Targeting inflammation in diabetic kidney disease: early clinical trials","volume":"25","author":"Perez-Gomez","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib57","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3390\/ph14070608","article-title":"Early renoprotective effect of ruxolitinib in a rat model of diabetic nephropathy","volume":"14","author":"El-Kady","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib58","article-title":"Relevance of the pyroptosis-related inflammasome pathway in the pathogenesis of diabetic kidney disease","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib59","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.3390\/ijms21124223","article-title":"Focus on the role of NLRP3 inflammasome in diseases","volume":"21","author":"Fusco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib60","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.3390\/ijms21197057","article-title":"New insights into the mechanisms of pyroptosis and implications for diabetic kidney disease","volume":"21","author":"Lin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib61","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.kint.2022.06.010","article-title":"Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease","volume":"102","author":"Shahzad","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib62","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3390\/nu14142965","article-title":"Neutrophil extracellular traps promote nlrp3 inflammasome activation and glomerular endothelial dysfunction in diabetic kidney disease","volume":"14","author":"Gupta","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154748","article-title":"Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy","volume":"118","author":"Wu","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib64","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1186\/s40001-024-02120-y","article-title":"Identification and validation of key extracellular proteins as the potential biomarkers in diabetic nephropathy","volume":"29","author":"Pan","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib65","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/antiox13040455","article-title":"Oxidative stress: a culprit in the progression of diabetic kidney disease","volume":"13","author":"Wang","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib66","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/biom14010137","article-title":"Kidney fibrosis and oxidative stress: from molecular pathways to new pharmacological opportunities","volume":"14","author":"Patera","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib67","doi-asserted-by":"crossref","DOI":"10.1093\/lifemeta\/load021","article-title":"Extracellular matrix remodelling in obesity and metabolic disorders","volume":"2","author":"Musale","year":"2023","journal-title":"Life Metab."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib68","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/ndt\/gfad238","article-title":"Endothelial to mesenchymal transition in kidney fibrosis","volume":"39","author":"Jacobs","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib69","article-title":"Signaling pathways involved in diabetic renal fibrosis","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib70","article-title":"TGF-\u03b2\/Smad signaling pathway in tubulointerstitial fibrosis","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib71","doi-asserted-by":"crossref","first-page":"7881","DOI":"10.3390\/ijms22157881","article-title":"TGF-beta as a master regulator of diabetic nephropathy","volume":"22","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib72","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","article-title":"Targeting fibrosis: mechanisms and clinical trials","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib73","series-title":"in: Diabetes and Kidney Disease","first-page":"601","article-title":"Novel treatments and the future of DKD: what is on the horizon?","author":"Wu","year":"2022"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib74","doi-asserted-by":"crossref","DOI":"10.2174\/1573399817666210309104203","article-title":"Diabetic complications: an update on pathobiology and therapeutic strategies","volume":"18","author":"Nellaiappan","year":"2022","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib75","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41581-022-00590-z","article-title":"The fibrogenic niche in kidney fibrosis: components and mechanisms","volume":"18","author":"Li","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib76","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1042\/CS20201016","article-title":"Interplay between extracellular matrix components and cellular and molecular mechanisms in kidney fibrosis","volume":"135","author":"Rayego-Mateos","year":"2021","journal-title":"Clin. Sci."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib77","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4239\/wjd.v13.i7.498","article-title":"Biochemical composition of the glomerular extracellular matrix in patients with diabetic kidney disease","volume":"13","author":"Adeva-Andany","year":"2022","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib78","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/biom5010194","article-title":"Advanced glycation end products and oxidative stress in type 2 diabetes mellitus","volume":"5","author":"Nowotny","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib79","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/jcm9020472","article-title":"Matrix metalloproteinases in diabetic kidney disease","volume":"9","author":"Garcia-Fernandez","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib80","series-title":"in: Diabetic Nephropathy","first-page":"227","article-title":"Mechanisms of interstitial fibrosis in diabetic nephropathy","author":"Loeffler","year":"2019"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib81","doi-asserted-by":"crossref","unstructured":"Q. Yuan, R.J. Tan, Y. Liu, Myofibroblast in Kidney Fibrosis: Origin, Activation, and Regulation, in: 2019: pp. 253\u2013283. https:\/\/doi.org\/10.1007\/978-981-13-8871-2_12.","DOI":"10.1007\/978-981-13-8871-2_12"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.569322","article-title":"New insights into the role and mechanism of partial epithelial-mesenchymal transition in kidney fibrosis","volume":"11","author":"Sheng","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib83","article-title":"Endothelial-to-mesenchymal transition: an underappreciated mediator of diabetic complications","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib84","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.3390\/ijms25063086","article-title":"Recent advances in the management of diabetic kidney disease: slowing progression","volume":"25","author":"Wang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib85","article-title":"The role of macrophages in kidney fibrosis","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib86","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.3390\/ijms24044004","article-title":"Fibrosis: types, effects, markers, mechanisms for disease progression, and its relation with oxidative stress, immunity, and inflammation","volume":"24","author":"Antar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib87","article-title":"Immune responses in diabetic nephropathy: pathogenic mechanisms and therapeutic target","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib88","article-title":"Macrophages in renal injury, repair, fibrosis following acute kidney injury and targeted therapy","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib89","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","article-title":"Macrophages: versatile players in renal inflammation and fibrosis","volume":"15","author":"Tang","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117079","article-title":"The role of macrophages in fibrosis of chronic kidney disease","volume":"177","author":"Li","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib91","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3390\/biom11070990","article-title":"The mechanism of CD8+\u2009T cells for reducing myofibroblasts accumulation during renal fibrosis","volume":"11","author":"Gao","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib92","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5009\/gnl220045","article-title":"Cellular and molecular mechanisms of intestinal fibrosis","volume":"17","author":"Wu","year":"2023","journal-title":"Gut Liver"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib93","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41420-023-01304-5","article-title":"Simultaneous blockade of VEGF-B and IL-17A ameliorated diabetic kidney disease by reducing ectopic lipid deposition and alleviating inflammation response","volume":"9","author":"Cao","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib94","article-title":"Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib95","first-page":"198","article-title":"Endothelial mesenchymal transformation and relationship with vascular abnormalities","volume":"15","author":"Chen","year":"2022","journal-title":"J. Radiat. Res. Appl. Sci."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib96","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.3390\/biomedicines11092408","article-title":"Protein-bound uremic toxins in senescence and kidney fibrosis","volume":"11","author":"Yang","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.683594","article-title":"EndMT Regulation by small RNAs in diabetes-associated fibrotic conditions: potential link with oxidative stress","volume":"9","author":"Giordo","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib98","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/14728222.2022.2133698","article-title":"Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-\u03b2) and related molecules","volume":"26","author":"Tang","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib99","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1111\/jcmm.17356","article-title":"Research progress of endothelial-mesenchymal transition in diabetic kidney disease","volume":"26","author":"Chen","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/molecules30010020","article-title":"Interrelation of natural polyphenol and fibrosis in diabetic nephropathy","volume":"30","author":"Ma","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib101","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1152\/physrev.00021.2018","article-title":"Endothelial to mesenchymal transition: role in physiology and in the pathogenesis of human diseases","volume":"99","author":"Piera-Velazquez","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib102","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/14728222.2020.1762173","article-title":"New therapeutic targets in chronic kidney disease progression and renal fibrosis","volume":"24","author":"Rayego-Mateos","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib103","article-title":"Epigenetic modification in diabetic kidney disease","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib104","doi-asserted-by":"crossref","unstructured":"T.-T. Ma, X.-M. Meng, TGF-\u03b2\/Smad and Renal Fibrosis, in: 2019,. 347\u2013364. https:\/\/doi.org\/10.1007\/978-981-13-8871-2_16.","DOI":"10.1007\/978-981-13-8871-2_16"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib105","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor\u2013\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib106","doi-asserted-by":"crossref","first-page":"a022095","DOI":"10.1101\/cshperspect.a022095","article-title":"Regulation of TGF-\u03b2 family signaling by inhibitory smads","volume":"9","author":"Miyazawa","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib107","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/wrr.12943","article-title":"Fibrosis: sirtuins at the checkpoints of myofibroblast differentiation and profibrotic activity","volume":"29","author":"Zullo","year":"2021","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib108","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3390\/ph15121485","article-title":"TGF-\u03b2 inhibitors for therapeutic management of kidney fibrosis","volume":"15","author":"Park","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib109","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3390\/genes11050496","article-title":"The role of wnt signalling in chronic kidney disease (CKD)","volume":"11","author":"Malik","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib110","doi-asserted-by":"crossref","first-page":"7349","DOI":"10.3390\/jcm12237349","article-title":"Pathomechanisms of diabetic kidney disease","volume":"12","author":"Sinha","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib111","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/fcp.13031","article-title":"Wnt\/beta-catenin modulation: a promising frontier in chronic kidney disease management","volume":"38","author":"Saxena","year":"2024","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib112","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2174\/1389450122666210216092218","article-title":"Canonical Wnt\/beta-catenin signaling network as emerging signaling cascade for therapeutic intervention in chronic renal disease","volume":"22","author":"Soni","year":"2021","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib113","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/0886022X.2017.1313164","article-title":"Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: an update","volume":"39","author":"Ying","year":"2017","journal-title":"Ren. Fail."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.830340","article-title":"Emerging therapeutic strategies for attenuating tubular EMT and kidney fibrosis by targeting Wnt\/\u03b2-catenin signaling","volume":"12","author":"Hu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib115","doi-asserted-by":"crossref","first-page":"90579","DOI":"10.18632\/oncotarget.21234","article-title":"Interactions between TGF-\u03b21, canonical WNT\/\u03b2-catenin pathway and PPAR \u03b3 in radiation-induced fibrosis","volume":"8","author":"Vall\u00e9e","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.701547","article-title":"The Wnt signaling pathway in diabetic nephropathy","volume":"9","author":"Wang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib117","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s11255-024-03989-8","article-title":"The role of PI3K\/Akt signaling pathway in chronic kidney disease","volume":"56","author":"Wang","year":"2024","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib118","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/10408363.2020.1746735","article-title":"Perspectives on the role of PTEN in diabetic nephropathy: an update","volume":"57","author":"Khokhar","year":"2020","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib119","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.apsb.2021.07.023","article-title":"Targeting PI3K\/AKT signaling for treatment of idiopathic pulmonary fibrosis","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib120","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/jcp.27262","article-title":"PI3k\/AKT signaling pathway: Erythropoiesis and beyond","volume":"234","author":"Jafari","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib121","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11010-018-3431-8","article-title":"TDCPP protects cardiomyocytes from H2O2-induced injuries via activating PI3K\/Akt\/GSK3\u03b2 signaling pathway","volume":"453","author":"Zhang","year":"2019","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib122","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1248\/bpb.b15-00127","article-title":"Relaxin inhibits high glucose-induced matrix accumulation in human mesangial cells by interfering with TGF-\u03b21 production and mesangial cells phenotypic transition","volume":"38","author":"Xie","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib123","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.phymed.2015.08.010","article-title":"Ethanolic Ginkgo biloba leaf extract prevents renal fibrosis through Akt\/mTOR signaling in diabetic nephropathy","volume":"22","author":"Lu","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114287","article-title":"AS101 prevents diabetic nephropathy progression and mesangial cell dysfunction: regulation of the AKT downstream pathway","volume":"9","author":"Shemesh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib125","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/jcb.25402","article-title":"PTEN regulates renal extracellular matrix deposit via increased CTGF in diabetes mellitus","volume":"117","author":"Zhu","year":"2016","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib126","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s00125-016-4021-5","article-title":"JAK inhibition in the treatment of diabetic kidney disease","volume":"59","author":"Brosius","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib127","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/molecules27030950","article-title":"Mechanistic insight into oxidative stress-triggered signaling pathways and type 2 diabetes","volume":"27","author":"Singh","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106339","article-title":"Natural essential oils efficacious in internal organs fibrosis treatment: mechanisms of action and application perspectives","volume":"182","author":"Yu","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib129","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2018.3714","article-title":"IL-1\u03b2 and TNF-\u03b1 suppress TGF-\u03b2-promoted NGF expression in periodontal ligament-derived fibroblasts through inactivation of TGF-\u03b2-induced Smad2\/3- and p38 MAPK-mediated signals","author":"Ohta","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib130","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.3390\/molecules27154922","article-title":"Receptor for advanced glycation end products (RAGE): a pivotal hub in immune diseases","volume":"27","author":"Yue","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib131","doi-asserted-by":"crossref","unstructured":"B.-C. Liu, T.-T. Tang, L.-L. Lv, How Tubular Epithelial Cell Injury Contributes to Renal Fibrosis, in: 2019: pp. 233\u2013252. https:\/\/doi.org\/10.1007\/978-981-13-8871-2_11.","DOI":"10.1007\/978-981-13-8871-2_11"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134139","article-title":"Baicalein, a bioflavonoid, prevents cisplatin-induced acute kidney injury by up-regulating antioxidant defenses and down-regulating the MAPKs and NF-\u03baB pathways","volume":"10","author":"Sahu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib133","doi-asserted-by":"crossref","unstructured":"J.-H. Zhao, Mesangial Cells and Renal Fibrosis, in: 2019: pp. 165\u2013194. https:\/\/doi.org\/10.1007\/978-981-13-8871-2_9.","DOI":"10.1007\/978-981-13-8871-2_9"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib134","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/dmrr.2568","article-title":"Research progress in signalling pathway in diabetic nephropathy","volume":"31","author":"Ni","year":"2015","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib135","doi-asserted-by":"crossref","first-page":"33807","DOI":"10.18632\/oncotarget.16995","article-title":"Pharmacologic targeting ERK1\/2 attenuates the development and progression of hyperuricemic nephropathy in rats","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib136","doi-asserted-by":"crossref","unstructured":"J. Barletto, S. Barros, R. Da, S. Santos, A. Adamski, S. Reis, Implication of the MAPK Signalling Pathway in the Pathogenesis of Diabetic Nephropathy, 2019.","DOI":"10.33590\/emjdiabet\/10311665"},{"key":"10.1016\/j.cytogfr.2025.05.007_bib137","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor\u2013\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib138","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2016.08.022","article-title":"Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: an update","volume":"791","author":"Bhattacharjee","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib139","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s10020-024-01020-5","article-title":"Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy","volume":"30","author":"Liu","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/08923973.2015.1127382","article-title":"TGF-\u03b2: the connecting link between nephropathy and fibrosis","volume":"38","author":"Sutariya","year":"2016","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib141","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.7150\/ijbs.71595","article-title":"Smad3 signatures in renal inflammation and fibrosis","volume":"18","author":"Wu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib142","article-title":"Signaling pathways involved in diabetic renal fibrosis","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib143","doi-asserted-by":"crossref","first-page":"F757","DOI":"10.1152\/ajprenal.00470.2011","article-title":"HSP47 regulates ECM accumulation in renal proximal tubular cells induced by TGF-\u03b2 1 through ERK1\/2 and JNK MAPK pathways","volume":"303","author":"Xiao","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cytogfr.2025.05.007_bib144","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3390\/cells9030706","article-title":"Role of c-Jun N-terminal kinase (JNK) in obesity and type 2 diabetes","volume":"9","author":"Yung","year":"2020","journal-title":"Cells"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135961012500053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135961012500053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T14:57:09Z","timestamp":1754751429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135961012500053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":144,"alternative-id":["S135961012500053X"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2025.05.007","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring inflammatory and fibrotic mechanisms driving diabetic nephropathy progression","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2025.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}